You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neuroendocrine Biomarkers

Showing 1 - 25 of 9,502
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Large Cell Neuroendocrine Carcinoma of the Lung Trial in Athens (Atezolizumab, Carboplatin, Etoposide)

Completed
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • Athens, Greece
  • +1 more
Sep 16, 2023

High Grade Neuroendocrine Tumors Trial in Saint Louis (Cabozantinib, Blood for plasma biomarkers, Tissue biopsy)

Recruiting
  • High Grade Neuroendocrine Neoplasms
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 11, 2021

Neuroendocrine Carcinoma Trial in France (FOLFOXIRI Protocol, Cisplatin injection)

Recruiting
  • Neuroendocrine Carcinoma
  • FOLFOXIRI Protocol
  • Cisplatin injection
  • Caen, France
  • +5 more
Apr 13, 2021

Midgut Neuroendocrine Tumors Trial in Toulouse (non-drug intervention type)

Unknown status
  • Midgut Neuroendocrine Tumors
  • non-drug intervention type
  • Toulouse, France
    CHU de Toulouse
Nov 9, 2020

Early Treatment Response in NEN (REBORN)

Recruiting
  • Neuroendocrine Tumors
  • +4 more
  • Somatostatin analog; chemotherapy
  • Rome, Italy
    Andrea M Isidori
Dec 2, 2020

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Carcinoma, Hepatocellular, Neuroendocrine Tumors Trial in Aarhus (Sorafenib, Radiofrequency ablation (RFA) or surgery,

Completed
  • Carcinoma, Hepatocellular
  • Neuroendocrine Tumors
  • Aarhus, Aarhus C, Denmark
    Department of Hepatology and Gastroenterology
Apr 27, 2021

Early and Advanced Pancreatic Ductal Adenocarcinoma and

Unknown status
  • Pancreatic Adenocarcinoma
    • Sutton, Surrey, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Feb 19, 2020

    Genetic Predisposition Testing Program for Pancreatic

    Not yet recruiting
    • Pancreatic Neuroendocrine Neoplasm
    • Hereditary Cancer Panel
    • Los Angeles, California
    • +2 more
    Feb 17, 2023

    Metastatic Malignant Tumor in the Viscera, Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation, Metastatic

    Not yet recruiting
    • Metastatic Malignant Neoplasm in the Viscera
    • +4 more
    • Lutetium Lu 177 Dotatate
    • (no location specified)
    Jan 25, 2023

    Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)

    Completed
    • Recurrent Neuroendocrine Tumor
    • Metastatic Neuroendocrine Tumor
    • Cleveland, Ohio
      Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
    Dec 1, 2022

    VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

    Recruiting
    • VHL Pancreatic Neuroendocrine Tumors
    • +2 more
    • 68-Gallium DOTATATE
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Carcinoid Tumor, Pancreatic Neuroendocrine Tumor Trial in Boston (Cabozantinib)

    Active, not recruiting
    • Carcinoid Tumor
    • Pancreatic Neuroendocrine Tumor
    • Boston, Massachusetts
    • +1 more
    Jul 15, 2022

    Idiopathic Intracranial Hypertension Trial in Montpellier (Blood punction, Central blood sampling, Intracranial pressure

    Not yet recruiting
    • Idiopathic Intracranial Hypertension
    • Blood punction
    • +2 more
    • Montpellier, France
      University Hospital of Montpellier - Gui de Chauliac
    Oct 2, 2023

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in United States (JBI-802)

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Denver, Colorado
    • +3 more
    Aug 19, 2022

    GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease Trial in United States

    Recruiting
    • GEP-NET
    • +6 more
    • Duarte, California
    • +3 more
    Jul 28, 2022

    Treatment Resistant Depression Trial in Chieti (Accelerated Repetitive Transcranial Magnetic Stimulation)

    Recruiting
    • Treatment Resistant Depression
    • Accelerated Repetitive Transcranial Magnetic Stimulation
    • Chieti, Italy
      ITAB
    Apr 3, 2023

    Carcinoid Tumor, Metastatic Carcinoid Tumor, Neuroendocrine Tumor Trial in Buffalo, Columbus (Laboratory Biomarker Analysis,

    Active, not recruiting
    Has Results
    • Carcinoid Tumor
    • +2 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Buffalo, New York
    • +1 more
    Nov 8, 2022

    Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

    Recruiting
    • Bladder Small Cell Neuroendocrine Carcinoma
    • +16 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Mar 23, 2022

    Neuroendocrine Tumors Trial (Lutathera)

    Not yet recruiting
    • Neuroendocrine Tumors
    • (no location specified)
    Aug 23, 2022

    Imaging Features in Invasiveness and Prognosis of Pituitary

    Recruiting
    • Pituitary Adenoma
    • Neuroendocrine Tumors
    • diagnosed and treated reasonably according to the clinical guidelines and clinical pathways
    • Guangzhou, Guangdong, China
      endocrinology department of the first affiliated hospital of Sun
    Aug 24, 2023

    Munich ME/CFS Cohort Study

    Recruiting
    • Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)
      • Munich, Bavaria, Germany
        MRI Chronic Fatigue Center for Young People (MCFC), Children's h
      Aug 16, 2023

      Neck Pain Trial in Loma Linda (cervical spinal manipulation, cervical spinal mobilization)

      Recruiting
      • Neck Pain
      • cervical spinal manipulation
      • cervical spinal mobilization
      • Loma Linda, California
        Loma Linda University
      Jun 14, 2022

      Neuroendocrine Tumor Trial in Beijing (Sintilimab, IBI310, Surufatinib)

      Recruiting
      • Neuroendocrine Neoplasm
      • Beijing, Beijing, China
      • +1 more
      Dec 7, 2021

      Breast Cancer Female, Breast Cancer Stage I, Breast Cancer Stage II Trial (Mindfulness-Based Cognitive Therapy (MBCT-Ca) -

      Recruiting
      • Breast Cancer Female
      • +3 more
      • Mindfulness-Based Cognitive Therapy (MBCT-Ca) - online
      • +2 more
      • Brno, Bohunice, Czechia
        Faculty of Medicine, Masaryk University
      Sep 15, 2022